Pancreastatin, porcine

CAS No. 106477-83-2

Pancreastatin, porcine( ——— )

Catalog No. M41487 CAS No. 106477-83-2

Pancreastatin (swine) is a49-residue peptide which strongly inhibits glucose-induced insulin release. Pancreastatin (swine) can be isolated and characterized from porcine pancreas.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 514 In Stock
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pancreastatin, porcine
  • Note
    Research use only, not for human use.
  • Brief Description
    Pancreastatin (swine) is a49-residue peptide which strongly inhibits glucose-induced insulin release. Pancreastatin (swine) can be isolated and characterized from porcine pancreas.
  • Description
    Pancreastatin (swine) is a49-residue peptide which strongly inhibits glucose-induced insulin release. Pancreastatin (swine) can be isolated and characterized from porcine pancreas.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    106477-83-2
  • Formula Weight
    5103.4
  • Molecular Formula
    C214H330N68O76S
  • Purity
    >98% (HPLC)
  • Solubility
    H2O : ≥ 100 mg/mL (19.59 mM)
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Tatemoto K, et al. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature. 1986 Dec 4-10;324(6096):476-8.?
molnova catalog
related products
  • Methyl benzoin

    Methyl benzoin is a biochemical.

  • Poricoic acid G

    Poricoic acid G shows inhibition of tumor-promoting effects and cytotoxic activity.

  • BC-1471

    STAMBP-IN-1 is a small-molecule inhibitor of STAMBP deubiquitinase, and interrupts STAMBP-Ub-NALP7 interaction. STAMBP-IN-1 decreases protein level of its inflammasome substrate NALP7 and suppresses IL-1b release after Toll-like receptor (TLR) agonism. STAMBP-IN-1 inhibits the activity of STAMBP to cleave recombinant di-Ub with an IC50 value of 0.33 mM